デフォルト表紙
市場調査レポート
商品コード
390818

医療ガス・機器の世界市場:製品、エンドユーザー、地域別の成長率、動向および予測

Medical Gases and Equipment Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 111 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.50円
医療ガス・機器の世界市場:製品、エンドユーザー、地域別の成長率、動向および予測
出版日: 2020年08月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 111 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

医療ガス・機器市場は、2018年から2023年の予測期間中に、約8.1%のCAGRで成長する見通しです。医療ガスは医療目的、医薬品処理およびバイオテクノロジーの研究に使用される特殊なガスです。医療ガスは、単一の純粋なガスまたは混合ガスです。使用されるガスの種類は、一般的に酸素、アンモニア、水素、亜酸化窒素、窒素、および二酸化炭素です。シリンダーやマスクなどのガス機器は、ガスの保管と配送に使用されています。

当レポートでは、世界の医療ガス・機器市場を調査し、全体的な市場動向、製品・地域別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場の概要

  • 現在の市場シナリオ
  • ポーターのファイブフォース分析
    • サプライヤーの交渉力
    • 消費者の交渉力
    • 新規参入の脅威
    • 代替製品とサービスの脅威
    • 業界内での競争

第6章 成長要因、阻害要因、機会、課題の分析(DROC)

  • 市場の成長要因
    • 大気汚染による肺疾患の増加
    • 高齢人口の増加
  • 市場の阻害要因
    • ヘリウムガスの不足
    • 規制の枠組みの懸念
  • 市場機会
  • 主な課題

第7章 市場セグメンテーション

  • 製品別
    • 医療ガス
  • エンドユーザー
    • 病院
    • 診療所
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第8章 競合情勢

  • M&A分析
  • 合意、コラボレーション、パートナーシップ
  • 新製品の発売

第9章 主要企業

  • Air Liquide
  • Airgas Inc.
  • Atlas Copco
  • Matheson tri Gas, Inc.
  • Messer Group GmbH
  • Praxair
  • 大陽日酸
  • The Linde Group
  • その他

第10章 市場の将来展望

目次
Product Code: 50695

The major factors driving the growth of the medical gases and equipment market include the rising demand for home healthcare and point-of-care diagnostics, the increasing burden of respiratory diseases, and favorable initiatives undertaken by government organizations.

  • Chronic respiratory diseases (CRDs) are chronic diseases of the airways and other structures of the lung. Common lung diseases are asthma, chronic obstructive pulmonary disease, occupational lung diseases, and pulmonary hypertension. According to WHO, more than 3 million people die each year from chronic obstructive pulmonary disease (COPDs), an estimated 6% of all deaths worldwide, and about 235 million people are suffering from asthma. WHO estimates COPD to become the third leading cause of death globally by 2030.
  • Though these are not curable, various forms of treatment help dilate air passages and improve shortened breath and increase the quality of life for people suffering from these diseases. Oxygen therapy is used for some chronic lung conditions, and COPD is one of these conditions. Oxygen is used to take the strain off one's heart, not lungs. It helps in preventing pulmonary artery hypertension. Long-term oxygen use can help relieve the strain on the heart. Other medical gases are also used to treat different chronic respiratory conditions, and the increasing prevalence of respiratory diseases acts as a driver for the growth of the medical gases and equipment market.

Key Market Trends

The Pure Medical Gases Sub-segment is Expected to Show Good Growth over the Forecast Period

The pure medical gas sub-segment is expected to be the fastest-growing segment, owing to the large usage of oxygen gas, as the oxygen gas provides a base for all modern anesthetic techniques and life support for artificially ventilated patients. The rising incidence of chronic diseases and road accidents across the world are major factors boosting the growth of the market. The patients admitted to intensive care units and ambulatory care for various types of surgeries require oxygen gas for life support. The oxygen supply sources are divided into two categories, namely bulk oxygen systems and cylinder-manifold-supply systems. According to the estimates of the Insurance Institute for Highway Safety (IIHS) and Highway Loss Data Institute (HLDI), in 2017, there were 34,247 motor vehicle crashes in the United States, leading to around 37,133 deaths. Thus, owing to the increasing cases of road accidents, there may be a huge demand for oxygen in various life care settings. Thus, due to the aforementioned factors, the market is expected to witness a high growth rate over the forecast period.

North America is Expected to Account for the Largest Market Share

North America held a major share in the medical gases and equipment market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. This steady growth rate is majorly attributed to the increasing use of medical gases and equipment in the management of various respiratory diseases, such as COPD and asthma. The growing incidences of COPD, asthma, and other medical conditions, such as cardiovascular and lifestyle-related diseases, are expected to drive the demand for medical gases and equipment in the United States, during the forecast period. The presence of state-of-the-art healthcare facilities, especially intensive care units, a well-established medical gas market, a high prevalence of patients with respiratory disorders, and the growing geriatric population have contributed to the largest share of the US market. In the United States, the medical gas sector is in the middle of a shift in standards, analysis, and delivery procedures, which results from the current increase in the use of home oxygen therapy to the modernization of medical gas standards and the means of supply.

Competitive Landscape

The market studied is moderately consolidated, owing to the presence of a few key players in the market. Some of the market players are Air Liquide, Air Products and Chemicals Inc., Amico Group of Companies, Atlas Copco, BeaconMedaes, the Linde Group, Flogas, Messer Group GmbH, Matheson Tri-Gas Inc., and Taiyo Nippon Sanso Corporation.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Home Healthcare and Point-of-care Diagnostics
    • 4.2.2 Increasing Prevalence of Respiratory Diseases
    • 4.2.3 Favorable Initiatives Undertaken by Government Organizations
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Process
    • 4.3.2 Limited Healthcare Reimbursement
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Medical Gases
      • 5.1.1.1 Pure Medical Gases
      • 5.1.1.2 Medical Gas Mixtures
      • 5.1.1.3 Biological Atmosphere
    • 5.1.2 Medical Gas Equipment
      • 5.1.2.1 Compressors
      • 5.1.2.2 Cylinders
      • 5.1.2.3 Hose Assemblies and Valves
      • 5.1.2.4 Masks
      • 5.1.2.5 Vacuum Systems
      • 5.1.2.6 Other Medical Gas Equipment
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Care
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Air Liquide
    • 6.1.2 Air Products and Chemicals Inc.
    • 6.1.3 Amico Group of Companies
    • 6.1.4 Atlas Copco
    • 6.1.5 BeaconMedaes
    • 6.1.6 Flogas
    • 6.1.7 Matheson Tri-Gas Inc.
    • 6.1.8 Messer Group GmbH
    • 6.1.9 Taiyo Nippon Sanso Corporation
    • 6.1.10 The Linde Group

7 MARKET OPPORTUNITIES AND FUTURE TRENDS